| 何百祥1，丁 丽2，张志峰3，鲍 刚1，汪 鑫1，李瑞春1，张瑞娟3常量硫酸镁治疗重型颅脑损伤的临床研究 |
| 论文编辑部-新丝路理论网 2011-03-31 15:52:59 作者:中华医学之家：http://www.xinxi85.com 来源: 文字大小:[大][中][小] |
|
Title:
Clinical study on routine-dose magnesium sulfate treatment in patients with severe traumatic brain injury
- 文章编号:
- 1671-8259(2011)02-0226-04
- 作者:
- 何百祥1; 丁 丽2; 张志峰3; 鲍 刚1; 汪 鑫1; 李瑞春1; 张瑞娟3
- 西安交通大学医学院：1. 第一附属医院神经外科；2. 第一附属医院检验科；3. 公共卫生系营养与食品卫生学教研室，陕西西安 710061
- Author(s):
- HE Bai-xiang1; DING Li2; ZHANG Zhi-feng3; BAO Gang1; WANG Xin1; LI Rui-chun1; ZHANG Rui-juan3
- 1. Department of Neurosurgery, the First Affiliated Hospital; 2. Department of Clinical Laboratory, the First Affiliated Hospital; 3. Department of Nutriology and
Food Sanitation, Medical School of Xi’an Jiaotong University, Xi’an 710061, China
- 关键词:
- ; 重型颅脑损伤; 镁离子; 常规剂量; 临床效果; 不良反应
- Keywords:
- ; severe traumatic brain injury; magnesium ion; routine dose; clinical efficacy; adverse resection
- 分类号:
- R651.1
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 摘要：目的 探讨常量硫酸镁治疗重型颅脑损伤(sTBI)的临床效果、用药方案及其安全性。方法 将入选病例随机分为治疗组和对照组，每组30例。对照组按常规治疗，治疗组加用常量硫酸镁。正常组20例，为成年健康献血员。按预设时间抽取肘静脉血，采用原子分光光度法测定血清Mg2+浓度。患者入院时、入院2周分别记录GCS评分。3月随访记录GOS评级并量化评分。观察记录治疗组和对照组患者伤后5d的不良反应情况。应用SPSS13.0软件包分析数据。结果 sTBI后对照组患者血清Mg2+浓度立即下降，24h内最低，7～14d基本正常。治疗组患者伤后2～3d血清Mg2+浓度明显高于对照组(P<0.01)，7～14d基本下降至正常。患者治疗2周后的GCS评分比较，治疗组高于对照组(P<0.05)。3月GOS评分治疗组高于对照组，但差异无统计学意义。治疗组和对照组患者sTBI后5d内出现的不良反应比较，差异无统计学意义。结论 常量硫酸镁治疗sTBI的近期疗效良好；伤后24h内用药、连用5d的用药方案是科学、有效、安全的。
- Abstract:
- ABSTRACT: Objective To investigate the clinical efficacy, protocol and safety of routine-dose magnesium sulfate treatment in patients with severe traumatic brain injury (sTBI). Methods The enrolled patients were randomly assigned to experimental group and control group, 30 in each group. Patients in control group were treated with conventional therapy while those in experimental group were treated with routine-dose magnesium sulfate apart from conventional therapy. Normal group consisted of 20 healthy adult blood donors. We collected blood samples at the preset time from the cases. Serum Mg2+ level was measured by atomic spectrometry. Patients’ GCS was recorded upon hospital admission and 2 weeks later respectively. Their GOS was recorded 3 months later; their adverse reactions were observed 5 days after injury. Then the data were analyzed by SPSS13.0 software package. Results The serum concentration of Mg2+ in control group dropped immediately and reached the floor level within 24 hours; it attained the normal level 7-14 days after sTBI. The serum level of Mg2+ 2-3 days after sTBI was higher in experimental group than in control group (P<0.01) and it dropped to the normal level 7-14 days after injury. After 2 weeks, GCS of patients in experimental group was higher than that in control group (P<0.05); 3 months later, the GOS of patients in experimental group was higher than that in control group, but without significant difference. Adverse reactions occurred 5 days after injury in experimental group and control group, but without significant difference. Conclusion A better short-term efficacy appears when sTBI is treated with routine-dose magnesium sulfate. The protocol has been proven scientific, effective and safe when routine-dose magnesium sulfate treatment in patients with sTBI begins within 24 hours of injury and lasts for 5 consecutive days.
参考文献/References
[1]樊德厚，王永利. 中国药物大全(西药卷) [M]. 第2版. 北京：人民卫生出版社, 1998:245.
[2]周国胜，赵洪洋，朱贤立，等. 大剂量硫酸镁对脑外伤治疗作用的研究 [J]. 中华创伤杂志, 2001, 11(3):161-162.
[3]VINK R, CERNAK I. Regulation of intracellular free magnesium in central nervous system injury [J]. Front Biosci, 2000,5(7):656-661.
[4]TURKOGLU OF, EROGLU H, OKUTAN O, et al. A comparative study of treatment for brain edema: magnesium sulphate versus dexamethasone sodium phosphate [J]. J Clin Neurosci, 2008, 15(1):60-65.
[5]何主强，赵甲山. 镁离子在治疗缺血性颅脑损伤中的研究进展 [J]. 中国微侵袭神经外科杂志, 2004, 9(9):423-425.
[6]张赛，李建伟，只达石，等. 外源性镁离子对重型颅脑损伤患者的治疗作用 [J]. 中华神经外科杂志, 2006, 2(22):76-78.
[7]傅小君，陈再丰，魏晓捷，等. 硫酸镁对急性重型颅脑损伤患者血清S-100B蛋白浓度的影响 [J]. 浙江创伤外科, 2006, 11(6):473-475.
[8]TEMKIN NR, ANDERSON GD, WINN HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial [J]. The Lancet Neurology, 2007, 6(1): 29-38.
[9]张赛. 镁离子对颅脑创伤患者的治疗作用 [J]. 中国现代神经疾病杂志, 2004, 4(3):149-150.
[10]MUIR KW, LEES KR. Dose optimization of intravenous magnesium sulfate after acute stroke [J]. Stroke, 1998, 29(5):918-923.
[11]VEYNA RS, SEYFRIED D, BURKE DG, et al. Magnesium sulfate therapy after aneurismal subaraehnoid hemorrhage [J]. J Neurosurg, 2002, 96(3):510-514.
[12]VAN DEN BERGH WM, ALBERCHT KW, BERKELBACH JW, et al. Magnesium therapy after aneurysmal subarachnoid haemorrhage: a dose-finding study for long term treatment [J]. Acta Neurochir (Wien), 2003, 145(3):195-199.
基金项目：陕西省卫生厅科研基金资助项目(No.08H30)
Supported by the Scientific Research Foundation of Shaanxi Provincial Health Department (No.08H30)
作者简介：何百祥(1965-)，男(汉族)，医学硕士，副主任医师，副教授. 研究方向：脊髓脊柱神经外科，颅脑损伤. E-mail: hbxsjwk@126.com
中华医学之家：http://www.xinxi85.com
投稿信箱：zhyxzj85@163.com
联系电话：029--85327298 主编QQ：693891972 |
|
|
|
|
百度百科
